DK1250152T3 - Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer - Google Patents
Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancerInfo
- Publication number
- DK1250152T3 DK1250152T3 DK00986939.7T DK00986939T DK1250152T3 DK 1250152 T3 DK1250152 T3 DK 1250152T3 DK 00986939 T DK00986939 T DK 00986939T DK 1250152 T3 DK1250152 T3 DK 1250152T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- composition containing
- hyaluronic acid
- synergistic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17337599P | 1999-12-28 | 1999-12-28 | |
PCT/CA2000/001562 WO2001047561A1 (en) | 1999-12-28 | 2000-12-28 | Hyaluronic acid in the treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1250152T3 true DK1250152T3 (da) | 2013-08-26 |
Family
ID=22631719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00986939.7T DK1250152T3 (da) | 1999-12-28 | 2000-12-28 | Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer |
Country Status (8)
Country | Link |
---|---|
US (1) | US7125858B2 (da) |
EP (1) | EP1250152B1 (da) |
JP (1) | JP4215429B2 (da) |
AU (1) | AU784356B2 (da) |
CA (1) | CA2395493C (da) |
DK (1) | DK1250152T3 (da) |
NZ (1) | NZ520312A (da) |
WO (1) | WO2001047561A1 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100374163C (zh) | 1999-01-13 | 2008-03-12 | 阿尔凯米亚肿瘤学私人有限公司 | 增强药物功效的组合物 |
CN101491536B (zh) * | 1999-12-13 | 2012-07-04 | 拜昂尼科生命科学有限公司 | 治疗用合成寡核苷酸 |
US20020091095A1 (en) * | 1999-12-13 | 2002-07-11 | Phillips Nigel C. | Modulation of Fas and FasL expression |
AUPQ879500A0 (en) * | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
US9066919B2 (en) | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
WO2002061085A2 (en) | 2000-10-31 | 2002-08-08 | Ryan James W | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
US7087586B2 (en) * | 2001-04-24 | 2006-08-08 | Bioniche Life Sciences, Inc. | Oligonucleotide compositions and their use to induce differentiation of cells |
ITPD20020271A1 (it) | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
JP4851185B2 (ja) | 2003-05-16 | 2012-01-11 | ジェレックスインターナショナル株式会社 | アレルギー症状抑制剤及び空気濾過フィルター |
US20060240084A1 (en) * | 2005-04-20 | 2006-10-26 | Xylos Corporation | Microbial cellulose materials for use in transdermal drug delivery systems, method of manufacture and use |
EP1912658B1 (en) * | 2005-07-27 | 2017-01-25 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
JP5627181B2 (ja) | 2005-09-07 | 2014-11-19 | アルケミア オンコロジー ピーティーワイ リミテッド | ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法 |
CA2671447A1 (en) | 2006-12-01 | 2008-06-12 | Anterios, Inc. | Amphiphilic entity nanoparticles |
DE102009035586A1 (de) | 2009-07-31 | 2011-02-03 | Fresenius Kabi Deutschland Gmbh | Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs |
CN102791861B (zh) | 2009-09-25 | 2018-08-07 | 库尔纳公司 | 通过调节聚丝蛋白(flg)的表达和活性而治疗flg相关疾病 |
DK2571979T3 (da) | 2010-10-13 | 2020-09-28 | Telesta Therapeutics Ip Inc | Bakterielle ribonukleinsyre-cellevæg-sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf |
WO2015036576A1 (en) * | 2013-09-12 | 2015-03-19 | Dsm Ip Assets B.V. | Ocular device |
CN110198703A (zh) | 2016-11-21 | 2019-09-03 | 艾里奥治疗公司 | 大试剂的透皮递送 |
JP2021031453A (ja) * | 2019-08-27 | 2021-03-01 | 国立研究開発法人物質・材料研究機構 | 炎症性サイトカイン産生抑制材、ヒアルロン酸誘導体、及び、ヒアルロン酸誘導体の製造方法。 |
CA3181682A1 (en) * | 2020-07-17 | 2022-01-20 | Anil Kapur | Subcutaneous telomerase inhibitor compositions and methods for using same |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172815A (en) * | 1962-04-24 | 1965-03-09 | Warner Lambert Pharmaceutical | Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof |
US4152423A (en) * | 1971-11-19 | 1979-05-01 | Agence Nationale De Valorisation De La Recherche (Anvar) | Immunological agents |
FR2160326B1 (da) * | 1971-11-19 | 1975-02-07 | Anvar | |
CA1020460A (en) * | 1973-02-23 | 1977-11-08 | Wellcome Foundation Limited (The) | Isolation of immunostimulating glycopeptide from bacteria |
US3976544A (en) * | 1973-06-19 | 1976-08-24 | The Agence Nationale De Valorisation De Le Recherche | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction |
FR2374042A1 (fr) * | 1976-06-04 | 1978-07-13 | Merieux Inst | Nouveau medicament immunostimulant et son procede de preparation |
JPS54140710A (en) * | 1978-03-10 | 1979-11-01 | Mitsui Toatsu Chem Inc | Anti-tumor substance and its preparation |
DE3011461C2 (de) * | 1980-03-25 | 1986-10-30 | Dr. Madaus & Co, 5000 Köln | Verwendung von Propionibakterien |
US4520019A (en) * | 1982-04-29 | 1985-05-28 | Ribi Immunochem Research, Inc. | Stable composition and preparation thereof |
US4579941A (en) * | 1982-08-13 | 1986-04-01 | Mitsuitoatsu Chemicals, Inc. | Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent |
US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
GB8404280D0 (en) * | 1984-02-17 | 1984-03-21 | Stanford J L | Biological preparations |
DE3408768A1 (de) | 1984-03-09 | 1985-09-12 | Bayer Ag, 5090 Leverkusen | Immunstimulierende mittel |
US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
EP0247071B1 (en) | 1985-10-31 | 1993-09-22 | The Australian National University | Immunotherapeutic treatment |
US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
US4837202A (en) | 1987-09-14 | 1989-06-06 | Pitman-Moore, Inc. | Method for stimulating the immune system |
DE3818054C2 (de) | 1988-05-27 | 1994-02-17 | Biotest Pharma Gmbh | Verwendung einer Kombination aus einem Antigen bzw. einer Vakzine und humanem Interleukin zur Behandlung der Non-Responsiveness gegenüber immunologischen Defektzuständen |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
WO1998017320A1 (en) | 1991-07-03 | 1998-04-30 | Hyal Pharmaceutical Corporation | Use of hyaluronan in gene therapy |
CA2122519C (en) | 1994-04-29 | 2001-02-20 | Rudolf Edgar Dr. Falk | Cancer treatment and metastasis prevention |
WO1994016727A1 (en) | 1993-01-29 | 1994-08-04 | Vetrepharm, Inc. | Immunotherapeutic composition |
AU6362594A (en) | 1993-03-10 | 1994-09-26 | Miles Inc. | Hyaluronic acid used as a cancer treatment |
IN181358B (da) * | 1995-02-14 | 1998-05-30 | Bioniche Inc | |
AU1991097A (en) | 1996-03-15 | 1997-10-01 | Immunotherapy, Inc. | Dialdehydes as immunostimulatory adjuvants and cross-linkers for producing immunogenic preparations and generating pressure and cross-linked treated cells for enhancing and augmenting the immune response against cancers, tumors and pathogenic diseases |
CA2208924A1 (en) | 1997-07-09 | 1999-01-09 | Hyal Pharmaceutical Corporation | Sparing paclitaxel by the use of hyaluronan |
US6326357B1 (en) * | 1997-08-05 | 2001-12-04 | Bioniche Life Sciences Inc. | Bacterial cell complex composition and method of use |
PT1054680E (pt) | 1998-02-18 | 2005-06-30 | Bioniche Life Sciences Inc | Tratamento do cancro da bexiga pela parede celular de mycobacterium phlei |
DE69920506T2 (de) | 1998-12-04 | 2005-10-13 | Bioniche Life Sciences Inc., London | Chemotherapeutische zusammensetzung und verfahren |
CN100374163C (zh) * | 1999-01-13 | 2008-03-12 | 阿尔凯米亚肿瘤学私人有限公司 | 增强药物功效的组合物 |
CA2266188A1 (en) | 1999-03-19 | 2000-09-19 | Stephen Chizick | Natural preparation for treatment of male pattern hair loss |
-
2000
- 2000-12-28 WO PCT/CA2000/001562 patent/WO2001047561A1/en active IP Right Grant
- 2000-12-28 EP EP00986939.7A patent/EP1250152B1/en not_active Expired - Lifetime
- 2000-12-28 AU AU23364/01A patent/AU784356B2/en not_active Ceased
- 2000-12-28 JP JP2001548149A patent/JP4215429B2/ja not_active Expired - Fee Related
- 2000-12-28 NZ NZ520312A patent/NZ520312A/en not_active IP Right Cessation
- 2000-12-28 CA CA2395493A patent/CA2395493C/en not_active Expired - Fee Related
- 2000-12-28 DK DK00986939.7T patent/DK1250152T3/da active
- 2000-12-28 US US10/168,327 patent/US7125858B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030176381A1 (en) | 2003-09-18 |
WO2001047561A1 (en) | 2001-07-05 |
JP4215429B2 (ja) | 2009-01-28 |
EP1250152B1 (en) | 2013-05-15 |
EP1250152A1 (en) | 2002-10-23 |
CA2395493C (en) | 2010-06-22 |
NZ520312A (en) | 2003-08-29 |
US7125858B2 (en) | 2006-10-24 |
CA2395493A1 (en) | 2001-07-05 |
JP2003518510A (ja) | 2003-06-10 |
AU784356B2 (en) | 2006-03-16 |
AU2336401A (en) | 2001-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2412368T3 (da) | Sammensætning til behandling af ar | |
DE60014873D1 (de) | Synergistische zusammensetzungen zur krebsbehandlung | |
DK1250152T3 (da) | Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer | |
DK1196163T3 (da) | Farmaceutiske sammensætninger til behandling af insulinresistens | |
PL351134A1 (en) | Compositions for treatment of disorders of the oesophagus | |
DK1173059T3 (da) | Fremgangsmåde til forögelse af biologisk virkningsfuldhed af plantebehandlingssammensætninger | |
NO20006630D0 (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
DK1259512T3 (da) | Pteridinforbindelser til behandling af psoreasis | |
IT1318649B1 (it) | Composizioni farmaceutiche per il trattamento di mucositi e stomatiti. | |
DK1384478T3 (da) | Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet | |
DK1450606T3 (da) | Synergistiske sammensætninger til behandling af såsæd | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DK1156806T3 (da) | Farmaceutisk sammensætning indeholdende protonpumpeinhibitor | |
DK1176964T3 (da) | Brug af ET743 til behandling af cancer | |
DK1150991T3 (da) | Præparater til behandling af inflammatoriske reaktioner | |
HUP0402341A3 (en) | Compositions containing thiazol-2-ylamines for the treatment of cancer | |
DK1150681T3 (da) | Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed | |
IL133760A0 (en) | Composition for the treatment of dandruff | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
ATE297187T1 (de) | Resorcinenthaltende zusammensetzung | |
NO20022000D0 (no) | 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon | |
DK1224181T3 (da) | Substituerede pyrroler som antiproliferative midler til behandling af cancer | |
DE10080787D2 (de) | Mikrobiozide Zusammensetzung | |
HK1043938A1 (en) | Composition for the treatment of psoriasis | |
ATE286391T1 (de) | Synergistische zusammensetzung zur krebsbehandlung |